Illumina Shares Gain 31% on AI Genomics Venture, Defying Overvaluation Concerns

source:

[1] Illumina (ILMN): Evaluating the Stock’s Valuation After Its Strategic AI-Genomics Partnership With MyOme (https://finance.yahoo.com/news/illumina-ilmn- ...)

Illumina Shares Gain 31% on AI Genomics Venture, Defying Overvaluation Concerns

Related News

BlackSky Stock Gains 80% as Gen-3 Satellite Goes Live

Google's Dual AI Strategy Wins as OpenAI User Growth Stalls

China's $1.076T Trade Surplus Fuels Yuan Appreciation Bets